Titre:
  • CDK4/6 inhibitors as adjuvant treatment for hormone receptor-positive, HER2-negative early breast cancer: a systematic review and meta-analysis
Auteur:Agostinetto, Elisa; Vian, Lucas; Caparica Bitton, Rafael; Bruzzone, Marco; Ceppi, Marcello; Lambertini, Matteo; Pondé, Noam; Azambuja, Evandro
Informations sur la publication:ESMO Open, 6, 2, page (100091)
Statut de publication:Publié, 2021-04
Sujet CREF:Généralités
Mots-clés:adjuvant
breast cancer
CDK4/6 inhibitors
endocrine therapy
HR-positive
survival
Note générale:SCOPUS: re.j
Langue:Anglais
Identificateurs:urn:issn:2059-7029
info:doi/10.1016/j.esmoop.2021.100091
info:pii/S205970292100048X
info:scp/85105894804
info:pmid/33743330